Inflammatory biomarkers and spontaneous preterm birth among obese women

References

• Blencowe H, Cousens S, Oestergaard MZ, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 2012;379:2162–72
   PubMed Web of Science ®Google Scholar
• Martin JA, Kung HC, Mathews TJ, et al. Annual summary of vital statistics: 2006. Pediatrics 2008;121:788–801
   PubMed Web of Science ®Google Scholar
• National Research Council. In: Behrman RE, Butler AS, eds. Preterm birth: causes, consequences, and prevention. Washington, DC: National Academies Press; 2007:400
   Google Scholar
• McCormick MC. The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med 1966;312:82–90
   Web of Science ®Google Scholar
• Saigal S, Doyle LW. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet 2008;371:261–9
   PubMed Web of Science ®Google Scholar
• Romero R, Dey SK, Fisher SJ. Preterm labor: one syndrome, many causes. Science 2014;345:760–5
   PubMed Web of Science ®Google Scholar
• Agrawal V, Hirsch E. Intrauterine infection and preterm labor. Semin Fetal Neonatal Med 2012;17:12–19
   PubMed Web of Science ®Google Scholar
• Elovitz MA, Wang Z, Chien EK, et al. A new model for inflammation-induced preterm birth: the role of platelet-activating factor and Toll-like receptor-4. Am J Pathol 2003;163:2103–11
   PubMed Web of Science ®Google Scholar
• Menon R, Furtunato SJ. Infection and the role of inflammation in preterm premature rupture of the membranes. Best Pract Res Clin Obstet Gynaecol 2007;21:467–78
   PubMed Web of Science ®Google Scholar
• Moore RM, Mansour JM, Redline RW, et al. The physiology of fetal membrane rupture: insight gained from the determination of physical properties. Placenta 2007;27:1037–51
   Web of Science ®Google Scholar
• Romero R, Gomez R, Chaiworapongsa T, et al. The role of infection in preterm labour and delivery. Paediatr Perinat Epidemiol 2001;15s2:41–56
   Web of Science ®Google Scholar
• Shaw GM, Wise PH, Mayo J, et al. Maternal prepregnancy body mass index and risk of spontaneous preterm birth. Paediatr Perinat Epidemiol 2014;28:302–11
   PubMed Web of Science ®Google Scholar
• Djelantik AA, Kunst AE, van der Wal MF, et al. Contribution of overweight and obesity to the occurrence of adverse pregnancy outcomes in a multi-ethnic cohort: population attributive fractions for Amsterdam. BJOG 2012;119:283–90
   PubMed Web of Science ®Google Scholar
• Wise LA, Palmer JR, Heffner LJ, Rosenberg L. Prepregnancy body size, gestational weight gain, and risk of preterm birth in African-American women. Epidemiology 2010;21:243–52
   PubMed Web of Science ®Google Scholar
• Mohamed-Ali V, Goodrick S, Bulmer K, et al. Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am J Physiol 1999;277:E971–5
   PubMed Web of Science ®Google Scholar
• Roytblat L, Rachinsky M, Fisher A, et al. Raised interleukin-6 levels in obese patients. Obes Res 2000;8:673–5
   PubMedGoogle Scholar
• Visser M, Bouter LM, McQuillan GM, et al. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999;282:2131–5
   PubMed Web of Science ®Google Scholar
• Jelliffe-Pawlowski LL, Walton-Haynes L, Currier RJ. Using second trimester ultrasound and maternal serum biomarker data to help detect congenital heart defects in pregnancies with positive triple-marker screening results. Am J Med Genet A 2008;146A:2455–67
   PubMed Web of Science ®Google Scholar
• Jelliffe-Pawlowski LL, Walton-Haynes L, Currier RJ. Identification of second trimester screen positive pregnancies at increased risk for congenital heart defects. Prenat Diagn 2009;29:570–7
   PubMed Web of Science ®Google Scholar
• Jelliffe-Pawlowski LL, Baer RJ, Currier RJ. Second trimester serum predictors of preterm birth in a population-based sample of low-risk pregnancies. Prenat Diagn 2010;30:727–33
   PubMed Web of Science ®Google Scholar
• Jelliffe-Pawlowski LL, Shaw GM, Stevenson DK, et al. Risk of bronchopulmonary dysplasia by second-trimester maternal serum levels of α-fetoprotein, human chorionic gonadotropin, and unconjugated estriol. Pediatr Res 2012;71:399–406
   PubMed Web of Science ®Google Scholar
• Jelliffe-Pawlowski LL, Ryckman KK, Bedell B, et al. Elevated mid-pregnancy tumor necrosis factor-α (TNF-α) and lipid patterns suggestive of hyperlipidemia in pregnancies resulting in early preterm birth. Am J Obstet Gynecol 2014 [Epub ahead of print]
   Web of Science ®Google Scholar
• Blumenfeld YJ, Baer RJ, Druzin ML, et al. Association between maternal characteristics, abnormal serum aneuploidy analytes, and placental abruption. Am J Obstet Gynecol 2014 [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Baer RJ, Currier RJ, Norton ME, et al. Obstetric, perinatal, and fetal outcomes in pregnancies with false-positive integrated screening results. Obstet Gynecol 2014;123:603–9
   PubMed Web of Science ®Google Scholar
• Jelliffe-Pawlowski LL, Baer RJ, Currier RJ, et al. Early-onset severe preeclampsia by first trimester pregnancy-associated plasma protein A and total human chorionic gonadotropin. Am J Perinatol 2015;32:703–12
   PubMed Web of Science ®Google Scholar
• Stringer EA, Baker KS, Carroll IR, et al. Daily cytokine fluctuations, driven by leptin, are associated with fatigue severity in chronic fatigue syndrome: evidence of inflammatory pathology. J Transl Med 2013;11:93
   PubMed Web of Science ®Google Scholar
• Breiman L. Random forests. Mach Learn 2001;45:5–32
   Web of Science ®Google Scholar
• Strobl C, Malley J, Tutz G. An introduction to recursive partitioning: rational, application, and characteristics of classification and regression trees, bagging, and random forests. Psychol Methods 2009;14:323–348
   PubMed Web of Science ®Google Scholar
• Breiman L, Friedman J, Stone CJ, Olshen RA. Classification and regression trees. Boca Raton (FL): CRC Press; 1984
   Google Scholar
• Carmieliet P, Ferreira V, Breier G, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996;380:435–9
   PubMed Web of Science ®Google Scholar
• Karkkainen MJ, Haiko P, Sainio K, et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 2003;5:74–80
   PubMed Web of Science ®Google Scholar
• Cheung CY. Vascular endothelial growth factor: possible role in fetal development and placental function. J Soc Gynecol Investig 1997;4:169–77
   PubMedGoogle Scholar
• Kumazaki K, Nakayama M, Suehara N, Wada Y. Expression of vascular endothelial growth factor, placental growth factor, and their receptors Flt-1 and KDR in human placenta under pathologic conditions. Hum Pathol 2002;33:1069–77
   PubMed Web of Science ®Google Scholar
• Lash GE, Cartwright JE, Whitley GJ, et al. The effects of angiogenic growth factors on extravillous trophoblast invasion and motility. Placenta 1999;20:661–7
   PubMed Web of Science ®Google Scholar
• Zhou Y, McMaster M, Woo K, et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol 2002;160:1405–23
   PubMed Web of Science ®Google Scholar
• Crispi F, Dominguez C, Llurba E, et al. Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction. Am J Obstet Gynecol 2006;195:201–7
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Romero R, Kim YM, et al. Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia. J Matern Fetal Neonatal Med 2005;17:3–18
   PubMed Web of Science ®Google Scholar
• Kim YN, Lee DS, Jeong DH, et al. The relationship of the level of circulating antiangiogenic factors to the clinical manifestations of preeclampsia. Prenat Diagn 2009;29:464–70
   PubMed Web of Science ®Google Scholar
• Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672–83
   PubMed Web of Science ®Google Scholar
• Almawi WY, Saldanha FL, Mahmood NA, et al. Relationship between VEGFA polymorphisms and serum VEGF protein levels and recurrent spontaneous miscarriage. Hum Reprod 2013;28:2628–35
   PubMed Web of Science ®Google Scholar
• Joukov V, Pajusola K, Kaipainen A, et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996;15:290–8
   PubMed Web of Science ®Google Scholar
• Lohela M, Saaristo A, Veikkola T, Alitalo K. Lymphangiogenic growth factors, receptors and therapies. Thromb Haemost 2003;90:167–84
   PubMed Web of Science ®Google Scholar
• Alitalo AK, Proulx ST, Karaman S, et al. VEGF-C and VEGF-D blockade inhibits inflammatory skin carcinogenesis. Cancer Res 2013;73:4212–21
   PubMed Web of Science ®Google Scholar
• Hagura A, Asai J, Maryuama K, et al. The VEGF-C/VEGFR3 signaling pathway contributes to resolving chronic skin inflammation by activating lymphatic vessel function. J Dermatol Sci 2014;73:135–41
   PubMed Web of Science ®Google Scholar
• Jurisic G, Sundberg JP, Detmar M. Blockade of VEGF receptor-3 aggravates inflammatory bowel disease and lymphatic vessel enlargement. Inflamm Bowel Dis 2013;19:1983–9
   PubMed Web of Science ®Google Scholar
• Skobe M, Hawighorst T, Jackson DG, et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2001;7:192–8
   PubMed Web of Science ®Google Scholar
• Malek TR, Bayer AL. Tolerance, not immunity, crucially depends on IL-2. Nat Rev Immunol 2004;4:665–74
   PubMed Web of Science ®Google Scholar
• Adachi K, Kumamoto T, Araki S. Interleukin-2 receptor levels indicating relapse in multiple sclerosis. Lancet 1989;1:559–60
   PubMed Web of Science ®Google Scholar
• Gallo P, Piccinno MG, Pagni S, et al. Immune activation in multiple sclerosis: study of IL-2, sIL-2R, and gamma-IFN levels in serum and cerebrospinal fluid. J Neurol Sci 1989;92:9–15
   PubMed Web of Science ®Google Scholar
• Giordano C, Galluzzo A, Marco A, et al. Increased soluble interleukin-2 receptor levels in the sera of type 1 diabetic patients. Diabetes Res 1988;8:135–8
   PubMedGoogle Scholar
• Greenberg SJ, Marcon L, Hurwitz BJ, et al. Elevated levels of soluble interleukin-2 receptors in multiple sclerosis. N Engl J Med 1988;319:1019–20
   PubMed Web of Science ®Google Scholar
• Kim HP, Imbert J, Leonard WJ. Both integrated and differential regulation of components of the IL-2/IL-2 receptor system. Cytokine Growth Factor Rev 2006;17:349–66
   PubMed Web of Science ®Google Scholar
• Makis AC, Galanakis E, Hatzimichael EC, et al. Serum levels of soluble interleukin-2 receptor alpha (sIL-2Ralpha) as a predictor of outcome in brucellosis. J Infect 2005;51:206–10
   PubMed Web of Science ®Google Scholar
• Romero R, Mazor M, Sepulveda W, et al. Tumor necrosis factor in preterm and term labor. Am J Obstet Gynecol 1992;166:1576–87
   PubMed Web of Science ®Google Scholar
• Pearce BD, Grove J, Bonney EA, et al. Interrelationship of cytokines, hypothalamic-pituitary-adrenal axis hormones, and psycho-social variables in the prediction of preterm birth. Gynecol Obstet Invest 2010;70:40–6
   PubMed Web of Science ®Google Scholar
• Coussons-Read ME, Lobel M, Carey JC, et al. The occurrence of preterm delivery is linked to pregnancy-specific distress and elevated inflammatory markers across gestation. Brain Behav Immun 2012;26:650–9
   PubMed Web of Science ®Google Scholar
• Ruan H, Hacohen N, Golub TR, et al. Tumor necrosis factor-α suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-α is obligatory. Diabetes 2002;51:1319–16
   PubMed Web of Science ®Google Scholar
• Chen X, Xun K, Chen L, Want Y. TNF-alpha, a potent lipid metabolism regulator . Cell Biochem Funct 2009;27:407–16
   PubMed Web of Science ®Google Scholar